Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
- Not FDA-approved for human use commonly available through research and compounding pharmacies
Product details Net content: 10 mg per vial Format: Lyophilized material Container: 3 mL glass vial Lot/batch: Recorded on product label where available Intended use Non-clinical laboratory research Analytical reference and assay development within institutional programs Use only in accordance with institutional SOPs and applicable regulatory requirements Not for human or animal consumption Not for clinical, therapeutic, diagnostic, cosmetic, or personal use Certificate of Analysis (COA) For full quality details, please refer to the second and third images on this page for the Certificate of Analysis (COA) for BPC-157 Canada 10mg
Receive a medical invoice after your consultation which you can submit to your medical aid for possible reimbursement (depending on your plan).
Express Australian shipping
A 2.5 mg track has short direct data and real-world support for stable maintainers, but continuing tirzepatide has much stronger evidence than stopping. At week 112, stepping down to 5 mg preserved 16.6% weight loss versus 21.9% on the top dose and 9.9% on placebo
Explore KPV Therapy GHK-Cu Copper Peptide Therapy Explore physician-guided GHK-Cu programs commonly discussed for skin, hair, tissue support and healthy-aging wellness goals
